Providers should not expect to see lower drug prices from a potential Walgreens Boots Alliance and AmerisourceBergen Corp. deal, analysts say.Original Article
Walgreens, AmerisourceBergen deal unlikely to cut drug prices
You may also like
Ninth Circuit Upholds FDA’s Authority to Regulate...
Skinny-Label Lives to See Another Day
Bring Out Your Meds! Bring Out Your Meds!
Homeopathic Industry Group Wants Court to Exclude It...
A Reversal on Sequencing? Proposed Legislation Would...
FDA Guidance Outlines a Framework for the Evaluation...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.